Filed: 11/14/2023ACC: 0000950123-23-010476
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $108.88M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$108.88M
Total AUM (reported)
30.56M
Total Shares
Allocation by class
COMMON STOCK$88.68M81.4%
COMMON STOCK CLASS A$20.20M18.6%
Portfolio Concentration
Top 3$81.29M74.7%
4–10$26.51M24.4%
11–25$1.07M1.0%
Top 3 weight
74.7%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 30.56M
Sole
Full voting authority
30.56M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
Replimune Group
SOLEShares3M
TypeSH
Market value$51.35M
47.17%
Sole
3M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$20.20M
18.55%
Sole
15.07M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$9.74M
8.94%
Sole
2.25M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares309.85K
TypeSH
Market value$7.10M
6.52%
Sole
309.85K
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$4.96M
4.56%
Sole
3.82M
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$4.88M
4.49%
Sole
2.16M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.27M
3.00%
Sole
843.75K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.63M
2.41%
Sole
1.79M
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$1.91M
1.76%
Sole
711.48K
Shared
0.00
None
0.00
Alpine Immune Sciences
SOLEShares153.70K
TypeSH
Market value$1.76M
1.62%
Sole
153.70K
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$992.5K
0.91%
Sole
251.27K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$80.9K
0.07%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Replimune GroupSOLE | Common Stock | 3M | SH | $51.35M 47.17% | 3M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $20.20M 18.55% | 15.07M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $9.74M 8.94% | 2.25M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 309.85K | SH | $7.10M 6.52% | 309.85K | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $4.96M 4.56% | 3.82M | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $4.88M 4.49% | 2.16M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.27M 3.00% | 843.75K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.63M 2.41% | 1.79M | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $1.91M 1.76% | 711.48K | 0.00 | 0.00 |
Alpine Immune SciencesSOLE | Common Stock | 153.70K | SH | $1.76M 1.62% | 153.70K | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $992.5K 0.91% | 251.27K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $80.9K 0.07% | 195.79K | 0.00 | 0.00 |